| Title : From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease - Chierrito_2017_Eur.J.Med.Chem_139_773 |
| Author(s) : Chierrito TPC , Mantoani SP , Roca C , Requena C , Sebastian-Perez V , Castillo WO , Moreira NCS , Perez C , Sakamoto-Hojo ET , Takahashi CS , Jimenez-Barbero J , Canada FJ , Campillo NE , Martinez A , Carvalho I |
| Ref : Eur Journal of Medicinal Chemistry , 139 :773 , 2017 |
| Abstract : Chierrito_2017_Eur.J.Med.Chem_139_773 |
| ESTHER : Chierrito_2017_Eur.J.Med.Chem_139_773 |
| PubMedSearch : Chierrito_2017_Eur.J.Med.Chem_139_773 |
| PubMedID: 28863358 |
Chierrito TPC, Mantoani SP, Roca C, Requena C, Sebastian-Perez V, Castillo WO, Moreira NCS, Perez C, Sakamoto-Hojo ET, Takahashi CS, Jimenez-Barbero J, Canada FJ, Campillo NE, Martinez A, Carvalho I (2017)
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease
Eur Journal of Medicinal Chemistry
139 :773
Chierrito TPC, Mantoani SP, Roca C, Requena C, Sebastian-Perez V, Castillo WO, Moreira NCS, Perez C, Sakamoto-Hojo ET, Takahashi CS, Jimenez-Barbero J, Canada FJ, Campillo NE, Martinez A, Carvalho I (2017)
Eur Journal of Medicinal Chemistry
139 :773